Fibromyalgia
Chronic pain condition with unknown causes and multidisciplinary treatment.
Fibromyalgia (FM) is a long-term condition defined by widespread chronic pain that persists for at least three months, occurring on both sides of the body and both above and below the waist. This pain can manifest as an ache, a burning sensation, or sharp, stabbing pain, and patients often experience heightened sensitivity where even the slightest touch can cause pain. Beyond pain, the condition involves a cluster of other core symptoms, including fatigue, cognitive problems (often termed "fibro fog"), unrefreshing sleep, lower abdominal pain or cramps, depression, and headache. Fatigue is a particularly prevalent and stubborn symptom, affecting about three-quarters of patients, and it does not improve with rest or sleep. Sleep disturbances are extremely common, occurring in up to 90% of patients, typically involving non-restorative sleep where individuals obtain a normal duration of sleep but wake feeling tired due to disruptions in sleep architecture. Cognitive difficulties affect roughly three-quarters of people with fibromyalgia, impacting concentration, memory, and multitasking. The condition was first recognized in the 1950s, formally defined in 1990, and has seen updated diagnostic criteria in 2011, 2016, and 2019. In the ICD-11, fibromyalgia is not listed as a standalone code but is included under "Chronic widespread pain." Research estimates that fibromyalgia affects 2 to 4% of the population, with women affected at a higher rate than men, and rates appear similar across different cultures and geographic regions. Treatment is symptomatic and multidisciplinary, with aerobic and strengthening exercise recommended, and medications such as duloxetine, milnacipran, and pregabalin providing short-term pain relief for some. Symptoms persist long-term in most patients, and the condition is associated with significant functional impairment, economic and social burden, stigma, and relatively high suicide rates.
Quick Facts
- Field
- Primary care
- Rheumatology
- Pain medicine
- Symptoms
- Widespread pain
- fatigue
- sleep problems
- Onset
- Early–middle age
- Duration
- Long term
- Causes
- Uncertain
- Diagnosis
- Based on symptoms after ruling out other potential causes
- Treatment
- Sufficient sleep and exercise, medication
- Medication
- Cyclobenzaprine
- duloxetine
- milnacipran
- pregabalin
Facts from the source article.
Lore & Background
The term derives from Neo-Latin fibro- ('fibrous tissues'), Greek myo- ('muscle'), and algos ('pain'), literally meaning 'muscle and fibrous connective tissue pain,' though this is considered inaccurate as it reflects only part of the symptom set. The abbreviation FM is increasingly used. The condition is characterized by chronic widespread pain lasting at least three months, occurring on both sides of the body and above and below the waist. Other key symptoms include fatigue, cognitive problems ('fibro fog'), unrefreshing sleep, depression, headache, and abdominal pain. Sleep disturbances occur in up to 90% of patients, and about 75% report significant problems with concentration, memory, and multitasking. Fibromyalgia is often comorbid with mental health issues, including anxiety, PTSD, and depressive disorders, and is associated with relatively high suicide rates.
Reader's Guide
Fibromyalgia represents a significant challenge in medicine due to its unknown causes, lack of a specific ICD-11 code (it is listed only as an inclusion under 'Chronic widespread pain'), and the stigma patients often face. Symptoms persist long-term in most patients. Research has identified potential subgroups within fibromyalgia based on symptom severity, personality, and treatment response, but more validation is needed. The condition imposes substantial economic and social burden, and patients frequently encounter doubt about the legitimacy of their symptoms. The high prevalence of comorbidities, including other chronic pain conditions and mental disorders, complicates diagnosis and management. Despite decades of study, the pathophysiology remains unclear, and fatigue—affecting 76% of patients—does not improve with sleep or medication, underscoring the need for continued research.
Frequently Asked Questions
What is Fibromyalgia known for?
Its 'powers' are essentially its symptom profile: persistent widespread pain, exhaustion, brain fog, and disrupted sleep that together significantly limit daily function. It plays the role of a long-term, multidisciplinary treatment challenge rather than a condition with a single definitive cure.
Who does Fibromyalgia affect most?
It strikes an estimated 2 to 4 percent of the general population, with women affected at a noticeably higher rate than men. Its reach also extends into economic and social spheres, adding layers of stigma even within healthcare settings.
More in Common Diseases & Disorders
Spotted an error? Know more?
Reader corrections go straight into our review queue. Suggest an edit · How this site is sourced